Work

A phase II trial of gemcitabine (G), cisplatin (C), and nab-paclitaxel (N) in advanced biliary tract cancers (aBTCs).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.4018

Authors: Rachna T. Shroff, Mitesh J. Borad, Lianchun Xiao, Ahmed Omar Kaseb, Gauri R. Varadhachary, Robert A. Wolff, Kanwal Pratap Singh Raghav, Michiko Iwasaki, Peter Masci, Ramesh K. Ramanathan, Daniel H. Ahn, Tanios S. Bekaii-Saab, Milind M. Javle

Institutions: The University of Texas MD Anderson Cancer Center, Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona)

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2802278528

Cites:

Cited by: 14

Related to: 10